Invention Grant
US08349557B2 Compositions and methods for diagnosis of autophagic vacuolar myopathy
失效
用于诊断自噬性液泡肌病的组合物和方法
- Patent Title: Compositions and methods for diagnosis of autophagic vacuolar myopathy
- Patent Title (中): 用于诊断自噬性液泡肌病的组合物和方法
-
Application No.: US12477555Application Date: 2009-06-03
-
Publication No.: US08349557B2Publication Date: 2013-01-08
- Inventor: Berge A. Minassian
- Applicant: Berge A. Minassian
- Applicant Address: CA Toronto
- Assignee: The Hospital for Sick Children
- Current Assignee: The Hospital for Sick Children
- Current Assignee Address: CA Toronto
- Agency: Vedder Price P.C.
- Agent Ajay A. Jagtiani
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C12Q1/68

Abstract:
Transmembrane V-ATPase proton pump complexes regulate pH of extracellular space or intracellular compartments of cells. V-ATPase complexes are ubiquitous in cells across species. A human orthologue of yeast vma21, LOC203547 (VMA21), is likely involved in the assembly of the V-ATPase. Hypomorphic mutations of VMA21 are identified from XMEA patients. Methods to diagnose and/or distinguish between different forms of vacuolar or vacuolated myopathy in an individual or patient are provided based either on the sequence of the VMA21 gene and/or the level and/or activity of the V-ATPase complex. Compositions of the present invention may comprise DNA, RNA, or protein molecules corresponding to all or a portion of VMA21 and including one or more of the mutations in VMA21 identified. Cultured cells or cell lines having one or more mutations in the VMA21 gene derived from patients having a form of vacuolar or vacuolated myopathy are provided.
Public/Granted literature
- US20090311704A1 COMPOSITIONS AND METHODS FOR DIAGNOSIS OF AUTOPHAGIC VACUOLAR MYOPATHY Public/Granted day:2009-12-17
Information query